{"id":"https://openalex.org/W2157259072","doi":"https://doi.org/10.1136/annrheumdis-2013-203229","title":"Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study","display_name":"Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study","publication_year":2013,"publication_date":"2013-06-06","ids":{"openalex":"https://openalex.org/W2157259072","doi":"https://doi.org/10.1136/annrheumdis-2013-203229","mag":"2157259072","pmid":"https://pubmed.ncbi.nlm.nih.gov/23740226","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4112444"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2013-203229","doi":"https://doi.org/10.1136/annrheumdis-2013-203229","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2013-203229","pdf_url":"https://ard.bmj.com/content/annrheumdis/73/8/1477.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ard.bmj.com/content/annrheumdis/73/8/1477.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008811878","display_name":"Bernard G Combe","orcid":"https://orcid.org/0000-0003-4002-1861","observed_orcids":["https://orcid.org/0000-0003-4002-1861"]},"institutions":[{"id":"https://openalex.org/I4210114166","display_name":"Institut de G\u00e9n\u00e9tique Mol\u00e9culaire de Montpellier","ror":"https://ror.org/02785qs39","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210096427","https://openalex.org/I4210114166"]},{"id":"https://openalex.org/I4210132125","display_name":"H\u00f4pital Lapeyronie","ror":"https://ror.org/03xzagw65","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210132125"]},{"id":"https://openalex.org/I4387153574","display_name":"Universit\u00e9 Montpellier 1","ror":"https://ror.org/0227fbx80","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307","https://openalex.org/I4387153574"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Bernard Combe","raw_affiliation_strings":["H\u00f4pital Lapeyronie, H\u00f4pital Lapeyronie, Universit\u00e9 Montpellier I, Montpellier, France","Departement de Rhumatologie, H\u00f4pital Lapeyronie, Universit\u00e9 Montpellier I, Montpellier UMR 5535, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Lapeyronie, H\u00f4pital Lapeyronie, Universit\u00e9 Montpellier I, Montpellier, France","institution_ids":["https://openalex.org/I4210132125","https://openalex.org/I4387153574"]},{"raw_affiliation_string":"Departement de Rhumatologie, H\u00f4pital Lapeyronie, Universit\u00e9 Montpellier I, Montpellier UMR 5535, France","institution_ids":["https://openalex.org/I4210114166","https://openalex.org/I4210132125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062360747","display_name":"Bhaskar Dasgupta","orcid":"https://orcid.org/0000-0002-5523-6534","observed_orcids":["https://orcid.org/0000-0002-5523-6534"]},"institutions":[{"id":"https://openalex.org/I4210093966","display_name":"Southend Hospital","ror":"https://ror.org/00p2x3741","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800288755","https://openalex.org/I4210093966"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bhaskar Dasgupta","raw_affiliation_strings":["Southend University Hospital, Westcliff-on-Sea, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southend University Hospital, Westcliff-on-Sea, UK","institution_ids":["https://openalex.org/I4210093966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072290078","display_name":"Ingrid Louw","orcid":"https://orcid.org/0000-0002-4271-0217","observed_orcids":["https://orcid.org/0000-0002-4271-0217"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ingrid Louw","raw_affiliation_strings":["Panorama Medical Centre, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Panorama Medical Centre, Cape Town, South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025298947","display_name":"Sarvajeet Pal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarvajeet Pal","raw_affiliation_strings":["Advance Rheumatology Clinic, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advance Rheumatology Clinic, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112722772","display_name":"J\u00fcrgen Wollenhaupt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101674","display_name":"Sch\u00f6n Klinik Hamburg Eilbek","ror":"https://ror.org/00pz61m54","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088209","https://openalex.org/I4210101674"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J\u00fcrgen Wollenhaupt","raw_affiliation_strings":["Sch\u00f6n Klinik Hamburg-Eilbek, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sch\u00f6n Klinik Hamburg-Eilbek, Hamburg, Germany","institution_ids":["https://openalex.org/I4210101674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091416598","display_name":"Cristiano A. F. Zerbini","orcid":"https://orcid.org/0000-0001-6269-2354","observed_orcids":["https://orcid.org/0000-0001-6269-2354"]},"institutions":[{"id":"https://openalex.org/I4210102483","display_name":"Hospital Heli\u00f3polis","ror":"https://ror.org/01bkdwe73","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210102483"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Cristiano A F Zerbini","raw_affiliation_strings":["Hospital Heli\u00f3polis, Servi\u00e7o de Reumatologia, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Heli\u00f3polis, Servi\u00e7o de Reumatologia, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I4210102483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104057851","display_name":"Andr\u00e9 D. Beaulieu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andre D Beaulieu","raw_affiliation_strings":["Centre de Rhumatologie, St-Louis, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Rhumatologie, St-Louis, Qu\u00e9bec, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079051965","display_name":"Hendrik Schulze\u2010Koops","orcid":"https://orcid.org/0000-0002-1681-491X","observed_orcids":["https://orcid.org/0000-0002-1681-491X"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hendrik Schulze-Koops","raw_affiliation_strings":["Rheumaeinheit, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumaeinheit, Med. Klinik and Poliklinik IV, University of Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083576726","display_name":"Patrick Durez","orcid":"https://orcid.org/0000-0002-7156-2356","observed_orcids":["https://orcid.org/0000-0002-7156-2356"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Patrick Durez","raw_affiliation_strings":["Service et P\u00f4le de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 catholique de Louvain, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service et P\u00f4le de Rhumatologie, Cliniques Universitaires Saint-Luc, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 catholique de Louvain, Brussels, Belgium","institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108307747","display_name":"Ruji Yao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruji Yao","raw_affiliation_strings":["Merck Sharp and Dohme, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme, Kenilworth, New Jersey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079518821","display_name":"Nathan Vastesaeger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121359","display_name":"MSD (Belgium)","ror":"https://ror.org/02j4p4h77","country_code":"BE","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210121359"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Nathan Vastesaeger","raw_affiliation_strings":["Merck Sharp and Dohme, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme, Brussels, Belgium","institution_ids":["https://openalex.org/I4210121359"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103975974","display_name":"Haoling Holly Weng","orcid":"https://orcid.org/0009-0002-8484-3955","observed_orcids":["https://orcid.org/0009-0002-8484-3955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haoling H Weng","raw_affiliation_strings":["Merck Sharp and Dohme, Kenilworth, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme, Kenilworth, New Jersey, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5008811878"],"corresponding_institution_ids":["https://openalex.org/I4210114166","https://openalex.org/I4210132125","https://openalex.org/I4387153574"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":{"value":4870,"currency":"USD","value_usd":4870},"fwci":4.6534,"has_fulltext":true,"cited_by_count":31,"citation_normalized_percentile":{"value":0.9526341,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"73","issue":"8","first_page":"1477","last_page":"1486"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/golimumab","display_name":"golimumab","score":1.0},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8679999709129333},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.9509999752044678},{"id":"https://openalex.org/keywords/tnf-antagonists","display_name":"TNF antagonists","score":0.7229999899864197},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.7850000262260437},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.7900000214576721},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9319999814033508},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.7720000147819519},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2781290027","wikidata":"https://www.wikidata.org/wiki/Q413879","display_name":"Golimumab","level":4,"score":0.9763008952140808},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9535543322563171},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6824955940246582},{"id":"https://openalex.org/C2778143017","wikidata":"https://www.wikidata.org/wiki/Q111208","display_name":"Erythrocyte sedimentation rate","level":2,"score":0.6578890085220337},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6439715027809143},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.490492045879364},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47285035252571106},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.46023866534233093},{"id":"https://openalex.org/C2777489490","wikidata":"https://www.wikidata.org/wiki/Q684924","display_name":"Rheumatism","level":2,"score":0.45227062702178955},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4106062650680542},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36032310128211975},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.238226056098938}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1136/annrheumdis-2013-203229","doi":"https://doi.org/10.1136/annrheumdis-2013-203229","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2013-203229","pdf_url":"https://ard.bmj.com/content/annrheumdis/73/8/1477.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4112444","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4112444","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Rheum Dis","raw_type":"Text"},{"id":"pmid:23740226","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23740226","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1000.4745","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1000.4745","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ard.bmj.com/content/early/2013/11/18/annrheumdis-2013-203229.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1004.1642","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1004.1642","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://ard.bmj.com/content/early/2013/06/05/annrheumdis-2013-203229.full.pdf","raw_type":"text"},{"id":"pmh:oai:dial.uclouvain.be:boreal:156554","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2078.1/156554","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases, Vol. 73, no. 8, p. 1477-1486 (2013)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:epub.ub.uni-muenchen.de:37228","doi":null,"is_oa":false,"landing_page_url":"https://epub.ub.uni-muenchen.de/37228/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401845","display_name":"Open access LMU (Ludwid Maxmilian's Universitat Munchen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I8204097","host_organization_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","host_organization_lineage":["https://openalex.org/I8204097"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"doc-type:article"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:73/8/1477","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/73/8/1477","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2013-203229","doi":"https://doi.org/10.1136/annrheumdis-2013-203229","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2013-203229","pdf_url":"https://ard.bmj.com/content/annrheumdis/73/8/1477.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2157259072.pdf","grobid_xml":"https://content.openalex.org/works/W2157259072.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1761300068","https://openalex.org/W1966756501","https://openalex.org/W1978383327","https://openalex.org/W1985812096","https://openalex.org/W1988975600","https://openalex.org/W2016528960","https://openalex.org/W2019832147","https://openalex.org/W2043597254","https://openalex.org/W2074270801","https://openalex.org/W2099559598","https://openalex.org/W2100125044","https://openalex.org/W2115008314","https://openalex.org/W2126583816","https://openalex.org/W2127696180","https://openalex.org/W2133866209","https://openalex.org/W2134171514","https://openalex.org/W2140965629","https://openalex.org/W2141259520","https://openalex.org/W2143972196","https://openalex.org/W2149223963","https://openalex.org/W2155109530","https://openalex.org/W2158058290","https://openalex.org/W2158131108","https://openalex.org/W2168792642","https://openalex.org/W2407688740","https://openalex.org/W2607079988"],"related_works":["https://openalex.org/W2790833340","https://openalex.org/W2107276084","https://openalex.org/W3201579239","https://openalex.org/W4307489660","https://openalex.org/W2328123150","https://openalex.org/W2160891870","https://openalex.org/W4405335625","https://openalex.org/W2331522319","https://openalex.org/W2563327068","https://openalex.org/W2496903537"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1,26],"evaluate":[2,27],"the":[3,175,182,260],"efficacy":[4,258],"and":[5,151,165,221],"safety":[6],"of":[7,75,138,148,154,177,219,249],"subcutaneous":[8,31,68,122,205,232,261],"golimumab":[9,33,69,123,206,220,233],"as":[10],"add-on":[11,65],"therapy":[12],"in":[13,35,50,55,95,226,235,239],"patients":[14,36,51,63,76,108,133,143,199],"with":[15,52,77,98,109,216],"active":[16,53],"rheumatoid":[17],"arthritis":[18],"(RA)":[19],"despite":[20],"disease-modifying":[21],"antirheumatic":[22],"drug":[23],"(DMARD)":[24],"treatment.":[25],"an":[28,45,252],"intravenous":[29],"plus":[30],"(IV+SC)":[32],"strategy":[34],"who":[37,201],"had":[38,144],"not":[39,113],"attained":[40,167],"remission.":[41,168],"METHODS:":[42],"GO-MORE":[43],"was":[44,93,129],"open-label,":[46],"multinational,":[47],"prospective":[48],"study":[49],"RA":[54],"typical":[56],"clinical":[57],"practice":[58],"settings.":[59],"In":[60,105],"part":[61,106,139],"1,":[62,140],"received":[64,202],"monthly":[66,231],"50-mg":[67],"for":[70],"6":[71,246],"months.":[72],"The":[73],"percentage":[74],"good/moderate":[78,162,236],"European":[79],"League":[80],"Against":[81],"Rheumatism":[82],"(EULAR)":[83],"28-joint":[84],"disease":[85,146],"activity":[86],"score":[87],"(DAS28)-erythrocyte":[88],"sedimentation":[89],"rate":[90],"(ESR)":[91],"response":[92,238],"compared":[94],"patient":[96],"subgroups":[97],"various":[99],"concurrent":[100],"or":[101,121,181,188,204],"previous":[102,217],"DMARD":[103,180,186],"treatments.":[104],"2,":[107],"EULAR":[110,163,170,237],"responses":[111,164,171],"but":[112,251],"remission":[114,128,209,244],"were":[115,134,172,195,214],"randomly":[116],"assigned":[117],"to":[118,124],"receive":[119],"IV+SC":[120,203,253],"month":[125,158],"12;":[126],"DAS28-ESR":[127,153],"measured.":[130],"RESULTS:":[131],"3366":[132],"enrolled.":[135],"At":[136,157],"baseline":[137],"3280":[141],"efficacy-evaluable":[142],"mean":[145,152],"duration":[147],"7.6":[149],"years":[150],"5.97":[155],"(SD=1.095).":[156],"6,":[159],"82.1%":[160],"achieved":[161,207,243],"23.9%":[166],"When":[169],"analysed":[173],"by":[174],"number":[176],"previously":[178],"failed":[179],"concomitant":[183],"methotrexate":[184],"dose,":[185],"type,":[187],"corticosteroid":[189],"use,":[190],"no":[191,256],"statistically":[192],"significant":[193],"differences":[194],"observed.":[196],"Part":[197],"2":[198],"(N=490)":[200],"similar":[208],"rates":[210],"(\u223c25%).":[211],"Adverse":[212],"events":[213],"consistent":[215],"reports":[218],"other":[222],"tumour":[223],"necrosis":[224],"antagonists":[225],"this":[227],"population.":[228],"CONCLUSIONS:":[229],"Add-on":[230],"resulted":[234],"most":[240],"patients;":[241],"25%":[242],"after":[245],"more":[247],"months":[248],"golimumab,":[250],"regimen":[254],"provided":[255],"additional":[257],"over":[259],"regimen.":[262]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}